Angiotensin II vs its type I antagonists: conformational requirements for receptor binding assessed from NMR spectroscopic and receptor docking experiments.Wilkes BC, Masaro L, Schiller PW, Carpenter KA, J Med Chem, 2002 Sep 26 - link